Global Esomeprazole Market Growth, Size, Share, Industry Report and Forecast 2020-2026
The esomeprazole market is expected to witness a modest growth rate during the forecast period 2020-2026. It is a proton pump inhibitor used to treat acid-related diseases. The high incidence of gastroesophageal reflux disease (GERD) is the chief reason for the growth of the market all across the globe. Its branded version is sold as Nexium, by AstraZeneca plc. It is among the most revenue-generating drug all across the globe, as the Nexium has alone generated more than $52.5 billion in the last two decades.
To Request a Sample of our Report on Global Esomeprazole Market: https://www.omrglobal.com/request-sample/esomeprazole-market
The major share of the esomeprazole market is generated from the
AstraZeneca plc, from the sales of Nexium. For instance, in 2019, the company
generated revenue of around $1.5 billion from the sales of Nexium. The sales of
the Nexium is decreasing every year as in 2018 and 2017, the revenue generated
from the Nexium sales was $1.7 billion and $1.9 billion respectively. It is due
to the increasing competition from the generic esomeprazole and sales of Nexium
rights in Europe. In October 2018, AstraZeneca plc has sold its Nexium rights
to Grünenthal GmbH for more than $700 million. Grünenthal GmbH generated a
revenue of $160 million in 2019 by the sales of Nexium in 2019.
A
full Report of Global Esomeprazole Market is Available at: https://www.omrglobal.com/industry-reports/esomeprazole-market
·
Erosive
Esophagitis
·
Gastroesophageal
Reflux Disease
·
Helicobacter
Pylori Infection
·
Other
By Type
·
Branded
·
Generic
By Dosage
Type
·
Capsules
& Tablets
·
Injections
·
Other
Regional
Analysis
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
Rest of APAC
Rest of The World
·
Middle
East & Africa
·
Latin
America
Company
Profiles
·
Alkem
Laboratories Ltd.
·
AstraZeneca
plc
·
Aurobindo
Pharma Ltd.
·
Cadila
Healthcare Ltd.
·
Chongqing
LUMMY Pharmaceutical Co., Ltd.
·
Dr.
Reddy’s Laboratories Ltd.
·
Glenmark
Pharmaceuticals Inc.
·
Grünenthal
GmbH
·
Laboratorios
Saval S.A.
·
Lannett
Co., Inc.
·
Mylan
N.V
·
Novartis
AG (Sandoz)
·
Sanofi
SA
·
Stada
Arzneimittel AG
·
Sun
Pharmaceutical Industries Ltd.
·
Teva
Pharmaceutical Industries Ltd.
Reasons for Buying from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More
Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/esomeprazole-market
About Orion
Market Research
Orion Market Research (OMR) is a market
research and consulting company known for its crisp and concise reports. The
company is equipped with an experienced team of analysts and consultants. OMR
offers quality syndicated research reports, customized research reports,
consulting and other research-based services.
For More Information, Visit Orion
Market Research
Media Contact:
Company Name: Orion Market
Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
Comments
Post a Comment